Table 2.
Plasma concentrations of biomarkers for out-of-hospital ventricular fibrillation in acute myocardial infarction (Group 1 + 2) as compared to patients with established cardiac disease without acute myocardial infarction (Group 4).
SCA with AMI Group 1 and 2 Mean (SD) | SCA without AMI Group 4 Mean (SD) | P-value | |
Conventional copeptin (pmol/L) | 719.4* (587.0) | 438.1† (302.9) | 0.111 |
Ultrasensitive copeptin (pmol/L) | 635.8 (542.1) | 363.4‡ (240.8) | 0.097 |
hs-cTnT (ng/L) | 246.0 (450.7) | 102.1 (115.1) | 0.332 |
NT-proBNP (pmol/L) | 67.06 (114.4) | 405.1 (569.9) | 0.000 |
Number of patients available for analyses: *n = 50, †n = 16, ‡n = 17.